The HeartAssist5® includes features such as FlowAccurate™ Diagnostics (direct blood flow measurement) available world-wide through our HeartAssistRemote™ Monitoring System. These exclusive features are available today only with the HeartAssist5®.
However, the true test for any LVAD is how well it matches the needs of the human heart it is assisting.
Promising results from implants of the new HeartAssist5® in Europe have begun to generate peer reviewed posters, presentations and papers documenting its performance. As these reports become available, ReliantHeart will distribute the findings, which we believe will document better results, and lower complications and side effects.
Smallest Size and Weight
The pump weighs only 92 grams, and is nearly silent.
The new HeartAssist5® VAD supports extra large adults to pediatric patients as small as 18 kg. It provides smooth, gentle blood flow from 2-10 L/min. For weaning patients whose own hearts are recovering, the HeartAssist5® provides precise blood flow as low as 2 L/min.
The HeartAssist5®’s small size is also one of the features that led to FDA approval as a Humanitarian Device Exemption (HDE) for use in pediatric patients in the United States. This indication is also CE Mark Approved for Europe. The HeartAssist5® can be implanted in children as young as four to six years old with a body surface area of 0.7m2 or larger.
A new intraventricular heart pump has made its debut.
Small outside at 2.48 centimeters in diameter and BIG inside with a 1.2 centimeter diameter flow tube. Deep linear channels transport blood safely through the pump away from the dangerous forces of radial shear. And the FastConnect system provides for adjustable pump depth inside the ventricle.
A modern approach to power management has produced generous start and running torque at 30% of the power consumption of other VADs. Batteries are smaller and last longer.
The intraventricular implant of the aVAD™ may facilitate a less invasive surgical technique.
The modern technology of TrueFlow measurement and 24/7 remote monitoring of TrueFlow, Speed and Power provide a sentinel system for early alert. For example TrueFlow and the Amplitude of TrueFlow can provide early warning of patterns of dehydration or atrial fibrillation.
Remote monitoring thrives on a modern world wide 3G Communication system carried seamlessly over 450 networks. Remote monitoring is in real time, all the time from anywhere.
ReliantHeart is currently designing a disconnectable cable for use with the aVAD™, making it forward compatible with a Transcutaneous Energy Transfer system (TET) under development at ReliantHeart; the Liberty system. LibertyTET is a power supply method that allows for power and data to be transmitted across the skin without the need for a wire exiting through the skin. Patients with an aVAD™ will be upgradable to the Liberty system in 2018.
- Improves Clinical Efficiency
- Enables Earlier Patient Intervention
- Enhances Patient Convenience
- Leverages Limited Staff and Health Care Resources
- Shows real time blood flow data
- Transmits blood flow and related data via secure wireless Internet for remote home monitoring via computers, or smartphones
- 21cm diagonal color touch screen display
- Sturdy all-in-one portable console
Heart failure is chronic and progressive. Based on your symptoms and quality of life, the progression of heart failure is divided into four classes by the New York Heart Association.
Advanced Heart Failure
As heart failure progresses, medications and surgery may no longer be adequate to manage this condition. These patients may benefit from a mechanical circulatory support device, such as a Left Ventricular Assist Device (LVAD).